US 7,598,231 B2Granted

Tricyclic compound, compositions, and methods

AssigneePfizer Inc.

InventorsHengmiao (Henry) Cheng, Rajesh Devraj, Gary A DeCresenzo, Xiao Hu, Kevin D. Jerome, Mark Obukowicz, Lisa Olson, Paul V. Rucker, Ronald Keith Webber

Life of this patent

Estimating the term…

Abstract

The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.

Claims6

Dependent claims

A compound of Formula I:

wherein R1 is —P(O)(OH)2;
or salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 12/023,362Filed 31 Jan 2008 · us provisional application
Priority: 2 Feb 2007
Published: US 2008/0188443 A17 Aug 2008
Granted: 6 Oct 2009
Term ends: Not estimatedThe source records don’t support an estimate.

Classification48 codes

C07D 213/89
Having three double bonds between ring members or between ring members and non-ring members: with hetero atoms directly attached to the ring…
A61K 31/44
Having six-membered rings with one nitrogen as the only ring hetero atom: non condensed pyridines; Hydrogenated derivatives thereof
A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system
A61P 1/02
Drugs for disorders of the alimentary tract or the digestive system: stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Family

Application60/887,981Us provisional application · filed 2 Feb 2007
US 2008/0188443 A1Pre-grant publication · published 7 Aug 2008
US 7,598,231 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results